ArticleJournal of biosciences2017

Constitutively activated ERK sensitizes cancer cells to doxorubicin: Involvement of p53-EGFR-ERK pathway.

Ratna Kumari et al.PubMed ↗Publisher ↗

No numbers read from the abstract.